FDA DEVICE FACTS
Metrix COVID Test; Metrix COVID Test Pro
Aptitude Medical Systems, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Metrix COVID Test: The Metrix COVID Test is a single-use (disposable) molecular in vitro diagnostic test for the qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA, that is used with the Metrix Reader (Gen 2). This test is intended for use with anterior nasal (AN) swab specimens, self-collected from individuals aged 14 years or older. This test is intended for individuals with signs and symptoms of COVID-19 (i.e., symptomatic). When testing without healthcare provider oversight, a negative test result is presumptive. Presumptive negative results should be confirmed with a lab-based molecular assay when determined to be appropriate by a healthcare provider. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for treatment. Individuals who test negative and experience continued or worsening respiratory symptoms such as fever, cough and/or shortness of breath should seek follow-up care with their healthcare provider. Positive results do not rule out infection with other respiratory pathogens. This test is not a substitute for visits to a healthcare provider or appropriate follow-up and should not be used to determine any treatments without provider supervision. Metrix COVID Test Pro: The Metrix COVID Test Pro is a single-use (disposable) molecular in vitro diagnostic test for the qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA, that is used with the Metrix Reader (Gen 2). This test is intended for use with anterior nasal (AN) swab specimens, self-collected from individuals aged 14 years or older. This test is intended for individuals with signs and symptoms of COVID-19 (i.e., symptomatic). When testing without healthcare provider oversight, a negative test result is presumptive. Presumptive negative results should be confirmed with a lab-based molecular assay when determined to be appropriate by a healthcare provider. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for treatment. Individuals who test negative and experience continued or worsening respiratory symptoms such as fever, cough and/or shortness of breath should seek follow-up care with their healthcare provider. Positive results do not rule out infection with other respiratory pathogens. This test is not a substitute for visits to a healthcare provider or appropriate follow-up and should not be used to determine any treatments without provider supervision.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。